Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Papillomavirus-Negative Neck Squamous Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01732640
What this trial is testing

A Phase I/II Study Afatinib/Carboplatin/Paclitaxel Induction Chemotherapy In HPV-Negative HNSCC.

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 9
Large-scale testing (Phase 3)Looking for participantsNCT06064877
What this trial is testing

Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

Who this might be right for
Metastatic Head-and-neck Squamous-cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma
AVEO Pharmaceuticals, Inc. 410
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06199271
What this trial is testing

Neoadjuvant Adebrelimab Plus Dalpiciclib in Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Zhongzheng Xiang 30
Very early researchEnded earlyNCT02827838
What this trial is testing

Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer

Who this might be right for
Human Papillomavirus InfectionStage I Oral Cavity Squamous Cell CarcinomaStage I Oropharyngeal Squamous Cell Carcinoma+9 more
Wake Forest University Health Sciences 17
Testing effectiveness (Phase 2)WithdrawnNCT01953952
What this trial is testing

Radiation Therapy and Cisplatin With or Without Surgery in Treating Patients With Stage III-IV Oropharyngeal Cancer

Who this might be right for
Stage III Squamous Cell Carcinoma of the OropharynxStage IVA Squamous Cell Carcinoma of the OropharynxTongue Cancer
Radiation Therapy Oncology Group
Early research (Phase 1)Study completedNCT03096054
What this trial is testing

A Phase I Trial of LY3143921 Hydrate in Solid Tumours

Who this might be right for
Colorectal CancerHigh Grade Serous Ovarian CancerNon Small-cell Lung Cancer (Squamous Cell Variant)+4 more
Cancer Research UK 69
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07484139
What this trial is testing

H&N NEO-COMBAT XL: Neoadjuvant XL-092 (Zanzalintinib) and Pembrolizumab (Keytruda) in Surgically Resectable, HPV Negative Oral Cavity Squamous Cell Carcinoma (OCSCC)

Who this might be right for
Oral Cavity Squamous Cell CarcinomaHead and Neck Cancer
UNC Lineberger Comprehensive Cancer Center 26
Early research (Phase 1)Study completedNCT03635164
What this trial is testing

Radiotherapy With Durvalumab Prior to Surgical Resection for HPV Negative Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
University of Colorado, Denver 21
Not applicableLooking for participantsNCT07512921
What this trial is testing

Matching Primary Tumor and Blood Gene Expression Analysis of HPV-negative Squamous Head and Neck Cancers

Who this might be right for
Head and Neck (HNSCC)
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT03323463
What this trial is testing

Major De-escalation to 30 Gy for Select Human Papillomavirus Associated Oropharyngeal Carcinoma

Who this might be right for
HPV-Associated Oropharyngeal Squamous Cell CarcinomaSquamous Cell Carcinoma of the Neck
Memorial Sloan Kettering Cancer Center 316